Andrew J Hall1,2,3, Nick D Clement2,4, Alasdair M J MacLullich3,5, Tim O White2,4, Andrew D Duckworth1,2,4,6. 1. Department of Orthopaedics and Trauma, University of Edinburgh, Edinburgh, UK. 2. Scottish Orthopaedic Research Trust into Trauma (SORT-IT), Edinburgh, UK. 3. Scottish Hip Fracture Audit (SHFA), NHS National Services Scotland, Edinburgh, UK. 4. Edinburgh Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, UK. 5. Department of Geriatric Medicine, Usher Institute, University of Edinburgh, Edinburgh, UK. 6. Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.
Abstract
AIMS: The primary aim was to determine the influence of COVID-19 on 30-day mortality following hip fracture. Secondary aims were to determine predictors of COVID-19 status on presentation and later in the admission; the rate of hospital acquired COVID-19; and the predictive value of negative swabs on admission. METHODS: A nationwide multicentre retrospective cohort study was conducted of all patients presenting with a hip fracture to 17 Scottish centres in March and April 2020. Demographics, presentation blood tests, COVID-19 status, Nottingham Hip Fracture Score, management, length of stay, and 30-day mortality were recorded. RESULTS: In all, 78/833 (9.4%) patients were diagnosed with COVID-19. The 30-day survival of patients with COVID-19 was significantly lower than for those without (65.4% vs 91%; p < 0.001). Diagnosis of COVID-19 within seven days of admission (likely community acquired) was independently associated with male sex (odds ratio (OR) 2.34, p = 0.040, confidence interval (CI) 1.04 to 5.25) and symptoms of COVID-19 (OR 15.56, CI 6.61 to 36.60, p < 0.001). Diagnosis of COVID-19 made between seven and 30 days of admission to hospital (likely hospital acquired) was independently associated with male sex (OR 1.73, CI 1.05 to 2.87, p = 0.032), Nottingham Hip Fracture Score ≥ 7 (OR 1.91, CI 1.09 to 3.34, p = 0.024), pulmonary disease (OR 1.68, CI 1.00 to 2.81, p = 0.049), American Society of Anesthesiologists (ASA) grade ≥ 3 (OR 2.37, CI 1.13 to 4.97, p = 0.022), and length of stay ≥ nine days (OR 1.98, CI 1.18 to 3.31, p = 0.009). A total of 38 (58.5%) COVID-19 cases were probably hospital acquired infections. The false-negative rate of a negative swab on admission was 0% in asymptomatic patients and 2.9% in symptomatic patients. CONCLUSION: COVID-19 was independently associated with a three times increased 30-day mortality rate. Nosocomial transmission may have accounted for approximately half of all cases during the first wave of the pandemic. Identification of risk factors for having COVID-19 on admission or acquiring COVID-19 in hospital may guide pathways for isolating or shielding patients respectively. Length of stay was the only modifiable risk factor, which emphasizes the importance of high-quality and timely care in this patient group. Cite this article: Bone Joint J 2021;103-B(5):888-897.
AIMS: The primary aim was to determine the influence of COVID-19 on 30-day mortality following hip fracture. Secondary aims were to determine predictors of COVID-19 status on presentation and later in the admission; the rate of hospital acquired COVID-19; and the predictive value of negative swabs on admission. METHODS: A nationwide multicentre retrospective cohort study was conducted of all patients presenting with a hip fracture to 17 Scottish centres in March and April 2020. Demographics, presentation blood tests, COVID-19 status, Nottingham Hip Fracture Score, management, length of stay, and 30-day mortality were recorded. RESULTS: In all, 78/833 (9.4%) patients were diagnosed with COVID-19. The 30-day survival of patients with COVID-19 was significantly lower than for those without (65.4% vs 91%; p < 0.001). Diagnosis of COVID-19 within seven days of admission (likely community acquired) was independently associated with male sex (odds ratio (OR) 2.34, p = 0.040, confidence interval (CI) 1.04 to 5.25) and symptoms of COVID-19 (OR 15.56, CI 6.61 to 36.60, p < 0.001). Diagnosis of COVID-19 made between seven and 30 days of admission to hospital (likely hospital acquired) was independently associated with male sex (OR 1.73, CI 1.05 to 2.87, p = 0.032), Nottingham Hip Fracture Score ≥ 7 (OR 1.91, CI 1.09 to 3.34, p = 0.024), pulmonary disease (OR 1.68, CI 1.00 to 2.81, p = 0.049), American Society of Anesthesiologists (ASA) grade ≥ 3 (OR 2.37, CI 1.13 to 4.97, p = 0.022), and length of stay ≥ nine days (OR 1.98, CI 1.18 to 3.31, p = 0.009). A total of 38 (58.5%) COVID-19 cases were probably hospital acquired infections. The false-negative rate of a negative swab on admission was 0% in asymptomatic patients and 2.9% in symptomatic patients. CONCLUSION:COVID-19 was independently associated with a three times increased 30-day mortality rate. Nosocomial transmission may have accounted for approximately half of all cases during the first wave of the pandemic. Identification of risk factors for having COVID-19 on admission or acquiring COVID-19 in hospital may guide pathways for isolating or shielding patients respectively. Length of stay was the only modifiable risk factor, which emphasizes the importance of high-quality and timely care in this patient group. Cite this article: Bone Joint J 2021;103-B(5):888-897.
Authors: Andrew J Hall; Nick D Clement; Alasdair M J MacLullich; A Hamish R W Simpson; Tim O White; Andrew D Duckworth Journal: Bone Joint Res Date: 2022-06 Impact factor: 4.410
Authors: Andrew J Hall; Nick D Clement; Alasdair M J MacLullich; A H R W Simpson; Antony Johansen; Tim O White; Andrew D Duckworth Journal: Bone Joint Res Date: 2022-06 Impact factor: 4.410
Authors: Andrew J Hall; Nicholas D Clement; Cristina Ojeda-Thies; Alasdair Mj MacLullich; Giuseppe Toro; Antony Johansen; Tim O White; Andrew D Duckworth Journal: Surgeon Date: 2022-03-28 Impact factor: 2.632
Authors: Vipin Asopa; Amit Sagi; Habeeb Bishi; Fanuelle Getachew; Irrum Afzal; Yiannis Vyrides; David Sochart; Vipul Patel; Deiary Kader Journal: Bone Jt Open Date: 2022-01
Authors: Alberto Grassi; Luca Andriolo; Davide Golinelli; Dario Tedesco; Simona Rosa; Pasquale Gramegna; Jacopo Ciaffi; Riccardo Meliconi; Maria Paola Landini; Giuseppe Filardo; Maria Pia Fantini; Stefano Zaffagnini Journal: Int J Environ Res Public Health Date: 2021-05-13 Impact factor: 3.390
Authors: Tomas Zamora; Felipe Sandoval; Hugo Demandes; Javier Serrano; Javiera Gonzalez; Maria Jesus Lira; Ianiv Klaber; Maximiliano Carmona; Eduardo Botello; Daniel Schweitzer Journal: Geriatr Orthop Surg Rehabil Date: 2021-07-09